Day 2 (Summary) @ #ECCMID2016. Keeping track of #AntimicrobialStewardship and other IT issues


I´m adapting to (some of) the new IT tools at #ECCMID2016. While, as said yesterday, the App is not very user-friendly, nor intuitive, I have to say that ECCMID live (Web) is really changing the way I select and summarize the take-home messages and sessions. The fact is that I feel that, in synergistic combination with Evernote®, it will facilitate the post-ECCMID review/consult throughout the year (Let´s be honest, this has never happened).


With ECCMID live and its almost real-time, all-in-one-site broadcasting is much more easier to mark/file and share on the go. If I had to choose, I prefer current Web & App combination to the former duet. Nevertheless if possible, unquestionably, App should be improved.


The #AntimicrobialStewardship path yesterday was:


  • OS051 – Modelling and metaanalyses of antimicrobial stewardship efficacy. To better understand the relationship between antimicrobial use and resistance is one of the needs for antimicrobial stewards since it would help to better taylor interventions as well as to better communicate the benefits of AS. It´s here were modeling can help. Nevertheless, modeling requires solid epidemiologically-based assumptions (critical for internal validation) and overall, (external) validation. Don´t miss Evelina Tacconeli´s meta-analysis (#O231) on the clinical effectiveness of antimicrobial stewardship (resistance-wise).


  • New antimicrobials (new yes, but from old families). I would keep these two sessions in your radar. First the Key Note lecture by the always-great Robert Bonomo on the renaissance of the beta-lactamase inhibitors (#K259). Second, an appraisal session on new antimicrobials (SY076) by David Paterson (new BLI), Angela Huttner (new oxazolidinone glycopeptides), Winfried Kern (Fluoroquinolones and new tetracyclines) and Ursula Theuretzbacher (miscellaneous).


  • Bloodstream infections. To note, from an antimicrobial stewardship perspective, the presentation by Eduardo López Cortes on the topic with a Quality Improvement (QI) perspective (#240). We should have in mind that QI and patient safety are two of the streams in which antimicrobial stewardship has to swim, in order to consolidate/improve its positioning in healthcare.


Just in case it was not enough, here you have some extras:

  • #K244 Vancomycin resistance in Staphylococcus aureus: nothing is what it seems to be (Benjamin Howden) Does S. aureus vanco issue drive you crazy? Then, take a seat and watch.


  • SY058 Food-producing animals as source of antibiotic resistance in humans (2h session)


  • The Year in Infectious Diseases (SY071) where Karin Thursky (antimicrobial resistance), Jordi Carratalá (clinical infectious diseases) and Souha Kanj (Tropical and Emerging Infectious Diseases) did a terrific job.


PS. Unfortunately there are some presenters that have not agreed yet (or perhaps haven´t had time to go with the paperwork) to share their presentation. If you know any of them, please ask them to do so because their presentations have been great. Some examples: Laureen Herwaldt and her presentation on decolonization strategies for CPE and Benjamin Lipsky (Diabetic Foot Infection)

Leave a Reply